William Hertlein

OPX Biotechnologies, Inc. engages in the development and production of bio-based chemicals and fuels. The company was founded by Ryan T. Gill, Peter Long, and Michael Lynch in 2007 and is headquartered in Boulder, CO.

ApopLogic Pharmaceuticals, Inc. researches and develops pharmaceutical products. It focuses on the development and commercialization of B201, is a rationally-designed synthetic peptide dimer of a potent decapeptide bradykinin B1&B2 receptor antagonist that directly induces apoptosis of cancer cells that overexpress these receptors and AP-300 is used in the neo-adjuvant or adjuvant setting with standard-of-care agents to improve survival outcomes in humans and companion animals with any accessible solid tumor including carcinomas, sarcomas and lymphomas. The company was founded in 2006 by Richard C. Duke, Donald Bellgrau, Paul A. Bunn, Daniel Chan, Lajos Gera, Jaime F. Modiano and John M. Stewart and is headquartered in Aurora, CO.

BSW Wealth Partners LLC (BSW) is an independent, SEC-registered investment advisor and wealth management firm headquartered in Boulder, Colorado. The firm was founded by Debi Baydush in 1992. BSW provides investment management services primarily to high net-worth individuals and families.

Founded in 2001, Macquarie Capital (USA), Inc. is a registered broker/dealer located in New York City. The firm is a subsidiary of Macquarie Bank Ltd. (ASX: MBL). They provide coverage of the following industries: resources, healthcare, security/defense, transportation, financial services, retail/consumer products, TMET (telecommunications, media, entertainment and technology), oil & gas, diversified manufacturing/distribution and infrastructure/utilities. Macquarie Capital (USA), Inc. is a member of FINRA.

DMC Biotechnologies, Inc. operates as an early-stage biotechnology company. The firm is the low cost sustainable transformation of multiple product markets. The company was founded by Matt Lipscomb and Mike Lynch in August 2014 and is headquartered in Boulder, CO.